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Morphology and cleavage rate remain the mainstay of embryo assessment. However, a number of additional technologies for this
application are under investigation. These include the measurement of glucose, lactate, pyruvate or amino acid levels in the
embryo culture media, assessment of oxygen consumption by the embryo, genomic and proteomic proﬁling, and most recently,
analytical examination of the embryonic metabolome. As the number of assisted reproduction cycles increases worldwide,
improvements in the ability to quickly and non-invasively identify the best embryos for transfer remain a critical goal for repro-
ductive medicine. Recent studies suggest that metabolomic proﬁling of embryo culture media using optical and non-optical spec-
troscopies may provide a useful adjunct to the current embryo assessment strategies and provide insight into the phenotype of
embryos with increasing reproductive potential.
Keywords: metabolomics; in vitro fertilization; non-invasive embryo assessment
Introduction
Soon after the report of the ﬁrst successful pregnancy with in vitro
fertilization (IVF) (Steptoe and Edwards, 1978), and development of
controlled ovarian stimulation in order to generate more than one
embryo in a given cycle (Trounson et al., 1981), it became apparent
that morphology and cleavage rate of embryos correlate with their
implantation potential (Edwards et al., 1984). Thereafter, grading
systems based on embryo cleavage rate and morphology were devel-
oped (Scott and Smith, 1998; Gardner and Schoolcraft, 1999; Gerris
et al., 1999; Tesarik and Greco, 1999; VanRoyan et al., 1999; Veeck,
1999) leading to signiﬁcant improvements in implantation and preg-
nancy rates and reductions in multiple gestation rates (Toner, 2002).
Today, among the treatment modalities offered to infertile couples,
those utilizing IVF are associated with the highest success rates. Con-
sequently, IVF use has been increasing steadily, from 64 681 cycles
reported in 1996 in the USA to 134 260 cycles in 2005 (SART,
1996, 2005). However, despite its widening application, IVF is cur-
rently associated with two important issues that derive, at least in
part, from our inability to adequately assess the reproductive potential
of individual embryos: (i) low implantation rates and (ii) high multiple
pregnancy rates.
Approximately two of three IVF cycles fail to result in pregnancy,
causing signiﬁcant physical, emotional and ﬁnancial distress for
women undergoing infertility treatment (SART, 2006). Even more
striking is the failure of more than 8 of 10 transferred embryos to
implant (Kovalevsky and Patrizio, 2005; Bromer and Seli, 2008).
Our inability to determine the embryos with highest reproductive
potential is likely to contribute to the high rate of implantation and
IVF cycle failures.
In order to prevent failures, centers have historically chosen to
perform simultaneous transfer of multiple embryos, accepting the
related risk of multiple pregnancies. In the USA, a mean number of
2.45 embryos were transferred in IVF cycles using fresh non-donor
oocytes in 2006, resulting in a 34.3% live birth rate per transfer, of
which 32% were multiple-infant live births (SART, 2006). Similarly,
a mean number of 2.3 embryos were transferred in IVF cycles using
fresh donor oocytes, achieving a 52.3% live birth rate per transfer,
40.8% of which were multiple-infant live births (SART, 2006). In
total, while IVF treatment accounts for only 1% of all births in the
USA, 18% of multiple births result from IVF. Moreover, 51% of all
IVF neonates are the products of multiple gestations (Wright et al.,
2006), a frequency of 15- to 20-fold greater than with spontaneous
conceptions (Reddy et al., 2007).
The high multiple pregnancy rates associated with IVF have signiﬁ-
cant public health consequences (Bromer and Seli, 2008) as the
increased rate of preterm delivery in multiple-infant pregnancies com-
promisesthesurvivalofneonatesandincreasestheirriskoflifelongdis-
ability. Indeed, while multiple births constitute approximately 1/33 of
all births in the USA, they account for 1/8 of preterm births (,37
weeks) and 1/4 of very low birthweight infants (,2000 g) (Luke and
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doi:10.1093/molehr/gan066Martin, 2004). Largely due to the increased incidence of prematurity,
cerebral palsy is increased 8-fold in twins and 47-fold in triplets
(Keith et al., 2000), while infant deaths (birth to 1 year) are increased
6-fold in twins, and 17-fold in triplets and higher order gestations
(Oleszczuk et al., 2003). Recently, it has been estimated that preterm
births that result from IVF-related multiple pregnancies, account for
$1 billion of cost to the society in the USA yearly (Bromer and
Seli, 2008). These estimations do not include maternal complications
associated with multiple gestations, including a 2- to 4-fold increase
in pregnancy induced hypertension and post-partum hemorrhage
(Luke and Brown, 2007).
The medical and ﬁnancial complications associated with multiple
pregnancies have now led a number of countries to impose legal
restrictions on the number of embryos transferred in IVF cycles
(Bromer and Seli, 2008). However, the majority of countries have
not yet adopted strict regulations with respect to IVF practice; most
probably due to high cost of treatment and patients’ desire to increase
their chances to achieve pregnancy in a given cycle. Consequently,
decreasing multiple gestations while maintaining or increasing
overall pregnancy rates is an important goal of contemporary inferti-
lity treatment, and an improvement over the current methods of
embryo assessment would be beneﬁcial for this purpose.
Embryo metabolism as a predictor of reproductive
potential
Given the limitations of morphologic evaluation, many investigators
have pursued adjunctive technologies for the assessment of the repro-
ductive potential of an embryo. Within this context, many metabolic
parameters of developing embryos have been studied using a variety
of non-invasive methods (Sakkas and Gardner, 2005). We will
brieﬂy review studies that investigated metabolomic parameters of
in vitro grown human embryos as they relate to embryo growth and
potential to result in a pregnancy. These studies demonstrate an under-
lying metabolic difference between embryos that result in a pregnancy
and those that do not, and form the basis of a metabolomic approach in
the assessment of embryo viability.
Pyruvate metabolism
There are two main pathways in ATP generation that are necessary for
embryoniccellularmetabolism:aeorobicglycolysis,orthetricarboxylic
acid(Krebs)cycle,andanaerobicglycolysis,bytheEmbden–Meyerhof
pathway. Carboxylic acid-based metabolism predominates in the early
preimplantation (cleavage stage) development, where pyruvate and
lactate are the embryo’s main sources of energy, and glucose uptake is
minimal (Biggers et al., 1967; Conaghan et al., 1993a). Consequently,
pyruvate uptake by embryos in culture has been investigated as a poss-
ible marker of embryo viability and growth potential.
Hardy et al. (1989) and Gott et al. (1990) reported higher pyruvate
uptake in embryos that develop to blastocyst stage (Table I). Cona-
ghan et al. (1993a,b), however, later reported contradictory ﬁndings
and demonstrated an inverse relationship between pyruvate uptake
by 2–8-cell embryos with embryo viability and pregnancy. A sub-
sequent report by Turner et al. (1994) suggested that embryos
display a wide range of pyruvate uptake values, but the variation is
reduced in those embryos that were capable of implantation.
Most recently, Gardner et al. (2001) assessed pyruvate uptake on
Day 4 embryos as it relates to development to blastocyst stage.
They found that pyruvate uptake on Day 4 is signiﬁcantly higher in
embryos that go on to form blastocysts compared with embryos that
fail to develop to the blastocyst stage, consistent with the initial
reports. Overall, it appears inconclusive whether pyruvate uptake is
predictive for embryo development and viability.
Glucose metabolism
The capacity to metabolize glucose increases signiﬁcantly at the tran-
sition from the morula to blastocyst stage and also seems to reﬂect the
embryo’s developmental potential and viability (Devreker, 2007).
Gardner and Leese (1987) measured glucose uptake by microﬂuores-
cence in Day 4 mouse blastocysts prior to embryo transfer. Embryos
that resulted in term pregnancies had a signiﬁcantly higher glucose
uptake in culture than embryos that failed to progress. Gardner et al.
(2001) also reported that the glucose consumption by Day 4 human
embryos was higher in embryos that formed blastocysts and correlated
with morphologic grade (Table I).
Table I. Pyruvate, lactate and glucose metabolism as a predictor of embryo development and viability—human studies.
Study Embryo stage examined Altered metabolite associated with
improved outcome
Technology used Outcome
Hardy et al. 1989 Day 2-4
Day 5
" pyruvate uptake
No association with glucose uptake
" pyruvate uptake
" glucose uptake
Ultramicroﬂuorescence assay
Ultramicroﬂuorescence assay
Blastocyst development
Blastocyst development
Gott et al. 1990 Day 2-4
Day 5
" pyruvate uptake
" lactate production
No association with glucose uptake
" pyruvate uptake
" glucose uptake
" lactate production
Ultramicroﬂuorescence assay
Ultramicroﬂuorescence assay
Blastocyst development
Blastocyst development
Conaghan et al., 1993 Day 2 – 3 # pyruvate uptake Ultramicroﬂuorescence assay Clinical pregnancy
Turner et al., 1994 Day 2 Intermediate pyruvate uptake Ultramicroﬂuorescence assay Clinical pregnancy
Gardner et al., 2001 Day 4 " pyruvate uptake
" glucose uptake
Ultramicroﬂuorescence assay Blastocyst development
Seli et al. Day 2-3 A trend toward
" pyruvate uptake
" glucose uptake
Proton NMR Pregnancy and delivery
Adapted from Bromer and Seli (2008).
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680Meanwhile, several other studies failed to demonstrate a relation-
ship between glucose uptake and blastocyst development in
human embryos (Hardy et al., 1989; Gott et al., 1990; Jones et al.,
2001). It is noteworthy that the media used to assess embryo metab-
olism in these studies lacked pyruvate, lactate, amino acids and vita-
mins. Thus, it is possible that there was signiﬁcant stress on the
embryos under these culture conditions (Lane and Gardner, 1998),
and the conclusions drawn may consequently have been limited by
this factor.
Amino acid metabolism
Using high-performance liquid chromatography (HPLC), Houghton
et al. (2002) determined the amino acids secreted and taken up by
human embryos, during different stages of preimplantation develop-
ment, correlated to blastocyst development. Their ﬁndings are sum-
marized in Table II. In a subsequent study, Brison et al. (2004) used
the same approach to examine the changes in concentration of
amino acids secreted by individually cultured human embryos. They
reported an association between decreased glycine and leucine, and
increased asparagine levels in the culture media with increased clini-
cal pregnancy and live birth rates. They also reported that embryos
with greater viability have a lower or quieter amino acid metabolism
than thosethat arrest. Sturmeyet al. (2008) reported similar ﬁndingsin
cryopreserved embryos, and Stokes et al. (2007) provided further
support for the quiet embryo hypothesis by demonstrating that the
metabolic activity of bovine, porcine and human embryos at the blas-
tocyst stage positively correlates with existing DNA damage.
Most recently, Seli et al. (2008a) have used proton nuclear magnetic
resonance (
1H NMR) and found an association between higher gluta-
mate levels in the culture media and clinical pregnancy and live birth.
Implications
The studies described above utilized a multitude of technologies and
have suggested that metabolic differences exist among embryos that
differ in their ability to result in a pregnancy. However, the application
of these technologies to a clinical setting has remained limited for a
variety of reasons. Many of these technologies require complex equip-
ment and dedicated technical staff, which would be cost prohibitive to
most embryology laboratories, and some do not produce results
quickly enough to allow the information to be used clinically in the
limited window of time acceptable for embryo transfer in the fresh
cycle. None of the technologies has ever been prospectively validated
on a test set of culture media samples, demonstrating a correlation
with the implantation potential of embryos that have been transferred.
Thus, the need remains for a validated technology that predicts viabi-
lity of embryos non-invasively, through a rapid, on-site evaluation of
multiple samples.
Metabolomics: the essentials
Metabolomics in systems biology
Evolvingfromgenomics, transcriptomics andproteomics, the emerging
‘omics’ science, metabolomics, is the systematic analysis of the inven-
tory of metabolites—as small molecule biomarkers—that represent the
functional phenotype at the cellular level (Appendix Table A1—Glos-
sary) (Posillico and Technologies, 2007). In particular, metabolomics is
usedtoexplain the underlyingchangeinmetabolicregulation as a func-
tion of disease and abnormal health conditions in a biological system
(cell, tissue or organism). Realization that obtaining the genome
sequence of humans or other species does not in itself explain the fun-
damental nature of many disease processes has increased interest in
approaches that relate gene expression to phenotypic outcome
Table II. Amino acid uptake and secretion by the embryo as a predictor of embryo development viability—human studies.
Study Embryo stage
examined
Altered metabolite associated with outcome Technology used Outcome
Houghton et al., 2002 Day 2 – 3
8 cell-Morula
# amino acid turnover (sum of depletion and appearance)
# glutamine, arginine, methionine uptake
# alanine and asparagine release
# amino acid turnover (sum of depletion and appearance)
# serine uptake
# alanine and glycine release
HPLC
HPLC
Blastocyst development
Blastocyst development
Brison et al., 2004 Day 2 # glycine and leucine in culture media
" asparagine levels in culture media
HPLC Clinical pregnancy and live birth
Seli et al. 2008 Day 3 " glutamate levels in culture media Proton NMR Clinical pregnancy and live birth
Adapted from Bromer and Seli (2008).
Table III. Examples of metabolites from the human metabolome and their physical (molecular weight) and chemical (chemical class, chemical formula)
properties.
Metabolite Chemical class Chemical formula Molecular weight (Da)
Urea Organic compound—amino ketone CH4N2O 60.06
Pyruvic acid Organic compound—keto-acid C3H4O3 88.06
Alanine Amino acid C3H7NO2 89.09
Glucose Carbohydrate—monosaccharide C6H12O6 180.16
Oleic acid Lipid—fatty acid C18H34O2 282.46
Lactose Carbohydrate—disaccharide C12H22O11 342.3
Cholesterol Lipid—steroid C27H46O 386.65
Adenosine triphosphate Nucleotide—co-enzyme C10H16N5O13P3 507.18
Glycogen Carbohydrate—polysaccharide C24H42O21 666.58
Oxytocin Peptide C43H66N12O12S2 1007.19
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681(Nicholson et al., 2002). Metabolomics offers a unique opportunity to
investigate the relationships between an organism’s genotype and its
resulting phenotype as the metabolome is the end product of gene
expression, and also marks a relationship between an organism’s physi-
ology and environmental conditions.
The metabolome refers to the complete inventory of small molecules
(,1 kDa), non-proteinaceous compounds such as metabolic intermedi-
ates (amino acids,lipidsand nucleotides), ATP, hormones, other signal-
ing molecules and secondary metabolites that are found within a
biological sample (Table III) (Posillico and Technologies, 2007; Pasi-
kanti et al., 2008). These compounds are the ultimate products of cellu-
lar metabolism and are very diverse in their physical and chemical
properties, occurring in a wide concentration range. As the number of
metabolites is typically lower than the number of genes and proteins
in a cell or organism, thorough metabolomic analysis can be achieved
in a relatively faster period of time than genomically related exper-
iments. It is generally agreed that there are more than 25 000 genes in
thehumangenome,encodingfor approximately100 000–200 000tran-
scripts, and 1 million proteins, whereas there may be as few as 2500–
3000 small molecule metabolites that make up the human metabolome.
Due to high labor and cost associated with proteomics and transcrip-
tomics, metabolomics has become a front running research tool in
understanding the ‘global picture’ of systems biology.
The metabolomics experiment is managed by a multidisciplinary
team of scientists in a workﬂow, from sample collection and prep-
aration through analytical operations to processing of raw data and
analysis of the processed data. Each step of the pipeline requires meti-
culous planning in order to extract the optimal amount of reproducible
information and interpret its biological signiﬁcance. As metabolomics
is a data-driven, inductive science, the proper methodology of analy-
sis, including key analytical technologies, must be selected in order to
remove any bias. Within the metabolomics platform, each analytical
approach offers an array of strengths and pitfalls, and are discussed
here and summarized in Appendix Table A2.
Analytical technologies
To investigate complex metabolic proﬁles of a biological system, non-
selective, but speciﬁc analytical technologies are required. Many spec-
troscopic/spectrometric and chromatographic techniques are excellent
candidates and provide automated, high-throughput methodologies
with information-rich proﬁles of target biological ﬂuids. Investigators
have coined the term ‘biospectroscopy’ to designate the analysis of bio-
logicalﬂuids by spectroscopic technologies. The scientiﬁc platform that
incorporates both metabolic proﬁling and biospectroscopy can be
referred to as ‘biospectroscopy-based metabolomics’ or ‘BSM’.
CommontechniquesappliedinBSMstudiesincludeNMRspectroscopy,
massspectrometry(MS),whichcanbecoupledwithseparationmethods
like gas chromatography (GC–MS), liquid chromatography (LC–MS)
orHPLC–MS,andcapillaryelectrophoresis(CE–MS).Opticalspectro-
scopies,likeFouriertransforminfrared(FT-IR),nearinfrared(NIR)and
Ramanspectroscopiesallprovidecomplementaryproﬁlesofthevarious
components withinbiological ﬂuids due tothe similar physical mechan-
isms involved in each technique.
Non-optical spectroscopy
Nuclear magnetic resonance (NMR) spectroscopy. One of the
most common and widely used spectroscopic techniques for
metabolomics is NMR spectroscopy (Fig. 1). Based on magnetic
properties of atomic nuclei, this technique provides a multivariate
analysis approach by non-destructively examining intact tissue and
biological ﬂuids (Nicholson et al., 2002). NMR is intrinsically rich
in information, offering structural and quantitative information
simultaneously, with metabolite identiﬁcation capabilities of even
the most complex of mixtures, without the need of separation or
sample preparation (Lindon, 2004). An important aspect of NMR
spectroscopy is that the fundamental physicochemical mechanism is
completely different from other analytical techniques and provides a
different scientiﬁc perspective (Pauli et al., 2005). However, NMR
spectroscopy is expensive, as highly advanced spectrometers with
Figure 1: NMR spectroscopy examples of pure component and biological
ﬂuid metabolomic analyses.
(A) Known chemical shift regions for proton NMR spectroscopy (0–12 ppm).
(B) Fourier transform proton NMR spectrum (0–5 ppm) of 6 mM lactic acid in
water obtained using a 500 MHz Varian spectrometer. (C) Fourier transform
proton NMR spectrum (0–5 ppm) of 18 mL spent IVF culture media in
600 mL 10% D2O/90% H2O obtained using a 500 MHz Varian spectrometer.
Ileu, isoleucine; Leu, leucine; Lact, lactate; Ala, alanine; Acet, acetate;
Meth, methionine; Glu, glutamate; Pyr, pyruvate; Gluc, glucose.
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682increasing magnetic ﬁeld strengths are required to make biological
measurements discernable. NMR experiments can also be
time-costly, ranging from less than a minute to a few hours per
measurement. In addition, the method requires highly trained
personnel to execute experiments and to interpret the resulting
spectra (Fig. 1). Although the NMR signal is intrinsically
quantitative, advanced software is required to extract such
information. Yet with each of these pitfalls, NMR remains a
spectroscopic method of choice for metabolomics.
Mass spectrometry. A counterpart to NMR spectroscopy that is
also used extensively in BSM is MS (Dettmer et al., 2007). Mass
spectrometers operate by ionization of metabolites, separation of
ionic fragments according to their mass-to-charge ratio and then
detection of these separated ions. As only medium-high abundant
chemicals can be detected by NMR spectroscopy (detection limit
0.1 mM (Bock, 1994)), MS-based metabolomics provides a more
analytically sensitive alternative with the ability to detect
metabolites at the micromolar concentration level, typical of
physiological concentrations (Dunn, 2008). MS is also capable of
quantitative analyses, and metabolite and structure identiﬁcation
through molecular weight determination. In a recent study,
Katz-Jaffe et al. (2006) applied MS to the analysis of embryo
culture medium and reported differences among the secretome of
embryos at different stages of development.
When MS is coupled with separation techniques, the complexity of
the mass spectrum is reduced and provides additional information on
the physiochemical properties of the metabolites. Chromatography is
the collective term for a family of laboratory techniques for the separ-
ation of mixtures. It involves passing a mixture in a ‘mobile phase’
through a ‘stationary phase’ (bound to columns and capillaries),
which separates the analytes to be measured into its comprising com-
ponents. Separation occurs as a result of the analytes afﬁnity for the
stationary phase, which is typically dependent on the physical (size)
or chemical (polarity) properties of the analyte. Chromatographic-
coupled MS usually requires thorough a priori knowledge of the
biological sample and may necessitate extensive sample preparation.
Consequently, chromatographic techniques can cause metabolite losses
by discrimination between metabolite classes (Pasikanti et al., 2008).
Gas chromatography–mass spectrometry (GC-MS). GC–MS
is biased towards volatile, thermally stable, low molecular weight
metabolites (,350 Da). As most of the metabolites are polar and
non-volatile in nature, they cannot be readily analyzed by GC–MS.
Therefore, this technique requires chemical derivatization at the
polar functional groups to reduce polarity and to increase thermal
stability and volatility (Pasikanti et al., 2008). Although these
processes allow the detection of many metabolite classes (including
amino acids, fatty acids and some lipids, sugars, sugar alcohols and
phosphates, amines, amides and thiol containing metabolites), this
extra processing step can introduce greater technical variability and
complexity to the data as a single metabolite can produce multiple
derivatized metabolite peaks (Dunn, 2008). Derivatization, extensive
sample preparation and long chromatographic analysis (10–
60 min per run) render GC–MS a relatively low-throughput
technique for metabolomic applications.
Liquid chromatography–mass spectrometry (LC-MS). A
related chromatographic technique, LC–MS, differs from GC–MS in
distinct ways as it not only operates in a different state of matter (with
a solid stationary phase and a liquid mobile phase), but can function at
both high and low temperatures and does not require sample volatility.
These conditions simplify sample preparation and make LC–MS a
better selection for the metabolomic analysis of biological ﬂuids.
Fluids like urine can be directly injected into an LC–MS system,
whereas samples such as plasma need minimal pretreatment (protein
precipitation) (Lu et al., 2008). As a result, LC–MS, and HPLC–MS
alike, are capable of moderate- to high-throughput sampling. It is also
applicable to a reasonable chemical dynamic range, with molecular
weights extending from low molecular weight species that are
detectable by GC–MS to molecular weights .600 Da. This chemical
inventory includes the analysis of phospholipids, proteins, amino
acids, glycosides and sugars (Dunn, 2008).
Capillary electrophoresis–mass spectrometry (CE-MS). A
ﬁnal separation method coupled to MS, which focuses on the
separation of charged metabolites is CE. Although CE–MS is used
to a lesser extent in metabolomics, it offers signiﬁcant potential with
its capability of analyzing a wide range of analytes from inorganic
ions to large proteins (Dunn and Ellis, 2005). As a major portion of
metabolites are polar and ionic, CE–MS can typically resolve
samples that may be more difﬁcult with conventional techniques
like GC or LC, without requiring rigorous sample preparation
(Montona and Soga, 2007). Yet the most attractive feature of CE is
its small sample requirement (few mL), making it useful for samples
that are limited by volume (Montona and Soga, 2007). However,
capillary and nanocolumn advances in HPLC may offer the same
low-volume requirement and offer greater advantages as an
analytical technology over CE.
The choice between NMR and MS approaches is ultimately matrix
or problem dependent. While chromatographic-coupled MS provides
an increase in sensitivity, the need to select and adjust experimental
conditions may result in an unintended bias to speciﬁc analytes.
Whereas the use of NMR spectroscopy is less selective and not chemi-
cally restricted, but continues to be challenged by its detection limits.
Combining both NMR spectroscopy and MS can yield complementary
information and prove to be useful in metabolomics studies (Lenz
et al., 2004; Williams et al., 2005; Wilsona et al., 2005). Still, both
technologies require further development, especially of high-
throughput and data-processing methods, to optimize their use in
complex metabolomic studies.
Optical spectroscopy
Ultimately, what limits the use of NMR and chromatographic MS tech-
nologies in clinical applications are the cost, reproducibility and practi-
calityasacommercial,‘bench-top’product.Althoughbothtechnologies
are excellent candidates in research applications, they are limited by
their size and complexity of operation. An alternative is the relatively
inexpensive and simple platforms of optical spectroscopies.
Optical spectroscopy measures the interaction of a species with
electromagnetic radiation—the electromagnetic radiation absorbed,
emitted or scattered by the sample analyzed. The term ‘optical spec-
troscopy’ in fact encompasses a broad range of analytical techniques
which includes ultraviolet/visible absorption, luminescence and circu-
lar dichroism spectroscopies (of which are not discussed herein), as
well as a subset of techniques that are more formally referred to as
‘vibrational spectroscopies’: IR, NIR and Raman spectroscopies.
Optical spectroscopic instrumentation is relatively simple compared
with that required for NMR or MS—it incorporates basic optical com-
ponents like light sources, mirrors, lenses, gratings and detectors. In
fact, some dispersive optical spectrometers incorporate no moving
parts at all, which results in very fast, highly reproducible measure-
ments. Additionally, these instruments are extremely stable over
time and can be easily maintained and operated by minimally
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rapid (common measurement times range from less than a second to a
few minutes) andnon-destructive analysis of a diverse range of sample
types (Dunn and Ellis, 2005).
Fourier transformation infrared (FT-IR) spectroscopy. FT-IR
is a well-established vibrational spectroscopic method that is
extensively used to analyze molecular species in biological samples.
The principle of FT-IR is based on molecular vibrational modes,
like stretching and bending of chemical bonds in a molecule. Upon
exposure to light (electromagnetic radiation), molecules will
increase in vibrational energy due to light absorbance and vibrate at
characteristic frequencies depending on their chemical structure.
Spectra of vibrational frequencies absorbed (between 400–
4000 cm
21 or 2500–25 000 nm) can then be correlated to single
bonds or functional groups of a molecule (–OH, –CH, –CH2,
–CH3, –NH, –NH2, –C¼O etc.). Multivariate analysis of several
spectral peaks generally allows for identiﬁcation of the various
components within a sample by matching the peak pattern(s) against
a library of previously recorded reference spectra of individual
components. FT-IR may also be used as a quantitative method for
determining concentrations of components within a sample.
Generally, FT-IR spectroscopy is able to analyze carbohydrates,
amino acids, lipids and fatty acids as well as proteins and
polysaccharides simultaneously (Dunn and Ellis, 2005). While
sensitivity and selectivity are not as high as methods like MS, the
fact that FT-IR is a high-throughput method, capable of
measuring thousands of spectra in a single day, should not be
overlooked. One drawback to FT-IR is that water absorbs IR
radiation very strongly, making analysis of aqueous samples
challenging. However, short path-length transmission cells and
attenuated total reﬂectance sampling accessories are both feasible
ways of recording FT-IR spectra from aqueous samples. In most
cases, water will still contribute the strongest features in the spectrum
and potentially interfere with the detection of some metabolites.
Near infrared (NIR) spectroscopy. Although FT-IR is used in
the vast majority of metabolomic studies, other classes of
vibrational spectroscopy are making headway in these applications.
Some work has been carried out using NIR spectroscopy (Fig. 2),
having signiﬁcant potential for metabolomics studies sharing many
of the same advantages as FT-IR. In particular, NIR spectroscopy
has been used to monitor lactate in the blood (Lafrance et al.,
2004), and metabolite content of culture media in IVF (Seli et al.,
2007). NIR differs from FT-IR in that it predominately measures
overtone and combination vibrational frequencies of functional
groups (R–H, N–H, C–H, S–H and O–H) (Fig. 2) between 700–
2500 nm (or 4000–14 300 cm
21). The vibrational transitions
corresponding to overtone and combination bands, as a result of
quantum mechanics, are at least an order of magnitude weaker in
comparison to fundamental transitions in the FT-IR spectral range.
However, relatively low NIR absorbance is advantageous in many
respects as many different types of materials (solids, aqueous
samples, tissues etc.) may be analyzed without sample preparation.
Also, instrumental cost and complexity is reduced compared with
IR spectrometers. The main drawback to NIR spectroscopy is that
the overtone and combination bands tend to be very broad and
overlapping relative to the sharp, well-separated fundamental
features found in the IR region (Fig. 2). As a result, multivariate
algorithms are required for analysis of NIR spectra to extract
chemically relevant information. One such method is to measure NIR
spectra of differing sample populations, followed by identiﬁcation of
spectral features that distinguish between them. As such, NIR
analysis is not typically used for target metabolite identiﬁcation, but
is used for overall spectral proﬁle comparisons. However, due to the
low absorbance and correspondingly longer path length in NIR,
multivariate models built from NIR data tend to be more accurate for
quantitative purposes than those derived from IR data.
Figure 2: NIR spectroscopy examples of pure component and biological ﬂuid
metabolomic analyses.
(A) Known combination and overtone NIR vibrational absorption bands of
organic molecules visible between 700 and 2500 nm. (B) NIR spectrum
(900–1700 nm) of 200 mM lactic acid in phosphatebuffered saline (PBS). Dis-
tinct absorption bands are visible for water (1390–1590 nm) and lactic acid
(1650–1700 nm). (C) NIR spectrum (900–1700 nm) of spent IVF culture
media (G1; VitroLife AB, Goteborg, Sweden) supplemented with 5% human
serum albumin (HSA; Irvine Scientiﬁc, Santa Ana, CA, USA). Broad combi-
nation and overtone vibrational bands are characteristic of these spectra.
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vibrational technique which ﬁnds application in the ﬁeld of
metabolomics. In a Raman experiment, a laser is utilized to promote
a vibrational excitation (Stokes) or relaxation (anti-Stokes) along a
molecular vibrational mode. By analyzing the scattered light from
the laser-illuminated sample, the amount of light absorbed at a
number of vibrational frequencies can be deduced. The resulting
spectrum contains vibrational fundamental information similar to
that seen in FT-IR/IR spectroscopy (400–4000 cm
21, Fig. 3) but
with a key difference. IR spectra tend to contain information from
asymmetric vibrational modes, while Raman spectra preferentially
reﬂect symmetric vibrational modes (Fig. 4). Thus, IR and Raman
are often considered to be perfectly complementary techniques:
when combined, they provide information on all of the fundamental
vibrational modes of a molecule. An advantage of Raman for
metabolomics is that water provides only very weak Raman signals,
making analysis of aqueous samples relatively straightforward.
However, unlike IR absorbance, Raman scattering is an intrinsically
insensitive spectroscopic technique. Some approximations put the
odds of Raman scattering in the order of one photon out of every
billion hitting the sample (Harris and Bertolucci, 1994). The newest
commercial Raman systems contain no moving parts and contain
compact, stable laser diode sources, resulting in affordable, robust
and portable instruments.
Non-invasive metabolomic proﬁling of embryo culture
media by vibrational spectroscopy to determine the
viability of individual embryos
Proof-of-concept studies
In 2007, Seli et al. (2007) reported the results of a proof-of-concept
study where Day 3 spent culture media of individually cultured
Figure 3: Raman spectroscopy examples of pure component and biological
ﬂuid metabolomic analyses.
(A) Known fundamental IR vibrational absorption bands of organic molecules
visible between 400 and 4000 cm
21.( B) Raman spectrum (0–4000 cm
21)o f
lactic acid. (C) Raman spectrum (0–3400 cm
21) of spent IVF culture media
(G1, VitroLife AB) supplemented with 5% human serum albumin (HSA;
Irvine Scientiﬁc).
Figure 4: Asymmetrical and symmetrical vibrational modes of water.
Figure 5: Viability scores calculated using (A) NIR and (B) Raman spectra of
culture media are shown for embryos that implanted and lead to delivery
(empty), and those that did not implant (shaded).
The implantation index values were signiﬁcantly different between the two
groups assessed by both NIR and Raman spectroscopy (P , 0.001). Modiﬁed
from Seli et al. (2007).
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and Raman spectroscopies (Fig. 5, Table IV). Using a multivariate
analysis approach, spectral proﬁles were compared between
embryos that resulted in live birth and embryos that failed to
implant. Spectral regions that discriminated between the two study
populations and were most predictive of pregnancy outcome were
identiﬁed as markers of oxidative stress, including vibrational
modes of –CH, –NH and –OH groups. These spectral regions were
then quantiﬁed in a multi-linear regression algorithm and expressed
as a viability score of each individual embryo’s potential to result in
a pregnancy and delivery.
In this initial study (Seli et al., 2007), using both NIR and Raman
spectroscopy, the mean viability score (also called viability index)
of embryos that implanted and resulted in a live birth was signiﬁcantly
higher (P , 0.01) compared with the mean viability score of embryos
that failed to implant (Fig. 5). Raman and NIR spectroscopies
achieved a sensitivity of 76.5% and 83.3%, and a speciﬁcity of 86%
and 75%, respectively. Moreover, the test was rapid (,1 min per
sample) and required a very small sample volume (,15 ml).
Subsequently, the regression algorithm for Raman spectra devel-
oped by Seli et al. (2007) described above was tested in a blinded
trial (Scott et al., 2008) analyzing Day 3 and Day 5 spent media col-
lected at a different IVF center, where embryos were cultured in a
different volume (50 ml instead of 30 ml) and type [Quinn’s Advan-
tage (SAGE) versus Scandinavian G1 (VitroLife)] of culture
medium. In this study, the previously developed algorithm was
applied to Raman spectra of embryo culture media and successfully
predicted the pregnancy outcome for embryos transferred on Day 3
and Day 5 (P , 0.05).
Validation studies using metabolomic proﬁling of embryo
culture media collected in single embryo transfer cycles
The initial studies described above were followed by studies with of
larger sample size from IVF centers that routinely perform single
embryo transfer (SET) (Kato et al., 2007; Hardarson et al., 2008;
Seli et al., 2008b; Vergouw et al., 2008). In these studies, spent
culture media were analyzed by NIR spectroscopy as described pre-
viously (Seli et al., 2007), and independent regression algorithms
for NIR spectra were developed for embryos that underwent SET on
Day 2 (n ¼ 121, Seli et al., 2008b; and n ¼ 29, Vergouw et al.,
2008), Day 3 (n ¼ 304, Vergouw et al., 2008) and Day 5 (n ¼ 137,
Hardarson et al., 2008). Consistent with the ﬁndings of the initial
studies (Seli et al., 2007; Scott et al., 2008), the more recent studies
using larger sample size and SET model, consistently showed higher
mean viability scores for embryos that resulted in a pregnancy with
fetal heart activity, compared with those that did not (Kato et al.,
2007; Hardarson et al., 2008; Seli et al., 2008b; Vergouw et al.,
2008). They also showed that metabolomic proﬁling of embryo
culture media was independent of morphology (Hardarson et al.,
2008; Seli et al., 2008b; Vergouw et al., 2008), providing an indepen-
dent parameter in embryo viability assessment. In addition, retrospec-
tive analysis suggested that combining morphology with metabolomic
proﬁling may improve identiﬁcation of embryos with higher implan-
tation potential (Seli et al., 2008b).
Most recently, spent culture media of 60 embryos collected follow-
ingSETonDay2wereevaluatedwithNIRspectroscopybyanobserver
blinded to pregnancy outcome, and viability scores were determined
using the regression algorithm previously established for Day 2
samples(Selietal.,2008b).Viabilityscoresofembryosthatimplanted
and resulted in fetal cardiac activity were higher compared with
embryosthatfailedtoimplant(P , 0.05).Inaddition,apositivecorre-
lation existed between increasing viability score values of individual
embryos and their potential to result in a pregnancy (P , 0.001).
Conclusions and future directions
The data summarized above strongly suggest that in vitro cultured
embryos that have a high implantation potential alter their environ-
ment differently compared to embryos that do not result in a preg-
nancy, and that the difference is detectable using non-invasive
metabolomic proﬁling of embryo culture media using biospectro-
scopy. Further investigation is necessary to validate the proposed
regression algorithms in different types and volumes of embryo
culture media and to determine whether an on-site testing will be clini-
cally valuable in aiding morphologic assessment.
A multitude of advantages may ensue from the use of a rapid, non-
invasive and reliable technology as an adjunct for embryo assessment.
An improved understanding of embryo viability may help in identify-
ing the embryos that are most likely to result in a pregnancy and allow
more accurate decisions to be madeabout the number of embryos to be
transferred. This in turn may reduce the likelihood of multiple ges-
tations while maintaining or even increasing implantation rates.
Table IV. Studies of non-invasive metabolomic proﬁling of embryo culture media to assess embryo viability in IVF.
Study Study design n Day of transfer Number of embryos
transferred
Analytical
technique
Center Findings
Seli et al. (2007) Algorithm development 36 Day 3 MET Raman YFC A
Scott et al. (2008) Blinded analysis 41 Day 3 and 5 MET Raman RMANJ B
Seli et al. (2007) Algorithm development 33 Day 3 MET NIR RMANJ A
Seli et al. (2007) Blinded analysis 16 Day 3 MET NIR YFC B
Seli et al. (2008b) Algorithm development 121 Day 2 SET NIR KLC A, C
Seli et al. (2008b) Blinded analysis 60 Day 2 SET NIR KLC B, D
Vergouw et al. (2008) Algorithm development 29 Day 2 SET NIR VUMC A, C
Vergouw et al. (2008) Seli et al. (2008b) Algorithm development 304 Day 3 SET NIR VUMC A, C
Hardarson et al. (2008) Algorithm development 137 Day 5 SET NIR FCG, SG A, C, D
SET, single embryo transfer; MET, multiple embryo transfer; YFC, Yale Fertility Center, New Haven, CT, USA; RMANJ, Reproductive Medicine Associates,
Morristown, New Jersey, USA; VUMC, Vrije Universiteit Medical Center, Amsterdam, The Netherlands; KLC, Kato Ladies Clinic, Tokyo, Japan; FCG,
Fertilitets centrum, Go ¨teborg, Sweden; SG, Shady Grove Fertility Reproductive Science Center, Rockville, Maryland, USA.
A, the mean viability score of embryos that implanted and resulted in fetal cardiac activity or live birth was signiﬁcantly higher compared with the mean
viability score of embryos that failed to implant; B, spectroscopic analysis by an observer blinded to pregnancy outcome, using a previously established
regression algorithm demonstrated that the mean viability score of embryos that resulted in a pregnancy was higher compared with embryos that failed to
implant; C, study showed the metabolomic proﬁle of embryo culture media to be independent of morphology; D, a positive correlation was detected between
increasing viability scores and the potential of individual embryos to result in a pregnancy.
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Conﬂict of interest: L.B. and D.S. are employed by the company developing
this technology for clinical application (Molecular Biometrics, LLC). E.S. and
D.S. serve on the scientiﬁc advisory board of Molecular Biometrics.
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Appendix
Table A1. Glossary of terms.
Biospectroscopy The analysis of biological ﬂuids by spectroscopic technologies
Capillary electrophoresis Analytical method of separation in which charged species migrate in a viscous medium under the inﬂuence of an electric ﬁeld.
Separation occurs as a result of varying mass-to-charge ratios
Chromatography Family of analytical methodologies for the separation of mixtures
Endometabolome Endogenous (intracellular) metabolites. These include amino acids, amines, sugars, steroids, nucleic acid bases and other substances
that are intermediates in cellular metabolism
Exometabolome Exogenous (extracellular) metabolites. This metabolome reﬂects the inﬂuence of the intracellular metabolic network on its external
environment, by the uptake of extracellular metabolites and secretion of intracellular metabolites
Gas chromatography Analytical method of separation in which a volatile sample is transported through a column by a ﬂow of an inert, gaseous mobile
phase. Separation occurs as a result of components varying afﬁnity for the stationary (liquid) phase in the column
Genomics A systematic study of an organism’s genome, including structural genes, regulatory sequences and non-coding DNA segments, and
its inﬂuence on biological pathways, networks and function
Liquid chromatography Analytical method of separation in which a liquid sample is transported through a column by a ﬂow of a liquid mobile phase.
Separation occurs as a result of components varying afﬁnity for the stationary (solid) phase in the column
Mass spectrometry Analytical method of separation and molecular weight determination of sample components. Components are ionized and separated
according to their mass-to-charge ratio
Metabolite Low molecular weight molecules (metabolites, typically ,1 kDa) present in a biologic environment that are participants in general
metabolic reactions and that are required for the maintenance, growth and normal function of a cell
Metabolome Qualitative and quantitative collection of all low molecular weight molecules (metabolites, typically ,1 kDa) present in a biologic
environment that are participants in general metabolic reactions and that are required for the maintenance, growth and normal
function of a cell
Metabolomics A systematic study of the inventory of metabolites—as small molecule biomarkers—that represent the functional phenotype
Metabonomics A quantitative measurement of multi-parametric metabolic responses of multi-cellular systems to pathophysiological stimuli or
genetic signaling. Can be interchanged with the term ‘metabolomics’
Non-optical spectroscopy Analytical spectroscopic/spectrometric technologies that do not measure the interaction of a species with electromagnetic radiation
and are based on alternative chemical and physical phenomena
Nuclear magnetic
resonance spectroscopy
Analytical spectroscopic technique that exploits the physical phenomenon based upon the quantum mechanical magnetic properties
of an atom’s nucleus. A sample is placed in an external magnetic ﬁeld and nuclear spin are excited by a resonant radio-frequency.
When the radio-frequency is turned off, the nuclei will relax and emit a detectable amount of energy
Optical spectroscopy Optical spectroscopy measures the interaction of a species with electromagnetic radiation—the electromagnetic radiation absorbed,
emitted or scattered by the sample analyzed
Proteomics The study encompassing the identiﬁcation and quantiﬁcation of proteins, and the effect of their modiﬁcations, interactions, activities
in a biological system
Systems biology The study and understanding of the interplays of different hierarchies of biological information (DNA, RNA, proteins,
macromolecular complexes, signaling networks, cells, organs, metabolic pathways) in a biological system, and how these
interactions give rise to the function and behavior of that system
Transcriptomics A systematic study of an organism’s transcriptome, the expression level of a complete set of messenger RNA molecules, in
understanding the involvement of genes and pathways in biological processes
Vibrational spectroscopy A subclass of optical spectroscopy that measures the absorbance and/or scattering of IR light as a result of molecular vibrational
transitions
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Analytical
technology
Description Chemical range Advantages Limitations
NMR
spectroscopy
Multivariate analysis based on
the quantum mechanical
magnetic properties of speciﬁc
atomic nuclei. A sample is
placed in an external magnetic
ﬁeld and nuclear spin are excited
by a resonant radio-frequency.
When the radio-frequency is
turned off, the nuclei will relax
and emit a detectable amount of
energy
Aqueous-based solutions
Organic solvent solutions
Complex biological mixtures of
small molecules and protein-rich
samples
Detection limits of 0.1 mM
Most metabolites
Examples: carbohydrates
(sugars—polysaccharide)
Amino acids
Lipids, fatty acids
Proteins
Non-destructive analysis of
biological ﬂuids and tissue
Provides quantitative and
structural information
simultaneously
Capable of extracting chemical
information of complex mixtures
without the need of separation
Increasing sensitivity with
increasing magnetic ﬁeld
strength
Expensive system as high
magnetic ﬁeld strength
spectrometers are required
Low throughput of samples
(depending on experimental
conditions)
Requires highly trained
personnel to execute experiments
and to interpret resulting spectra
Requires computational software
to extract spectral and
quantitative information
GC–MS Chromatographic-coupled mass
spectrometry. A volatile sample
is transported through a column
by a ﬂow of an inert, gaseous
mobile phase. Separation occurs
as a result of components’
varying afﬁnity for the stationary
(liquid) phase in the column.
Mass spectrometry operates by
ionization of metabolites,
separation of ionic fragments
according to their
mass-to-charge ratio, and then
detection of these separated ions
Low molecular weight
compounds (,350 Da)
Volatile and thermally stable
molecules
Detection limits of mM
Examples: some lipids (fatty
acids)
Amino acids
Sugars and sugar alcohols
Organic compounds (phosphates,
amines, amides, thiols)
Analytically sensitive (detection
limits ,mM)
Molecular structure
determination
Metabolite identiﬁcation through
molecular weight determination
Analysis of many metabolite
classes after derivatization
Cannot readily analyze polar,
non-volatile analytes without
derivatization
Low throughput (10–60 minutes
per analysis)
Sample preparation can
introduce greater technical
variability and data complexity
A priori sample knowledge
required
Requires maintenance and highly
trained personnel to execute
experiments
LC–MS Chromatographic-coupled mass
spectrometry. A liquid sample is
transported through a column by
a ﬂow of a liquid mobile phase.
Separation occurs as a result of
components varying afﬁnity for
the stationary (solid) phase in
the column.
Mass spectrometry operates by
ionization of metabolites,
separation of ionic fragments
according to their
mass-to-charge ratio, and then
detection of these separated ions
Molecular weights extending
from those detectable by GC–
MS to molecular weights
.600 Da
Detection limits of mM
Examples: amino acids
Peptides
Sugars and Glycosides
Organic compounds
Lipids (fatty acids,
phospholipids)
Proteins
Analytically sensitive
Can operate at both high and
low temperatures Does not
require sample volatility
Larger chemical dynamic range
Limited sample preparation
required without the need of
derivatization
Direct injection possible
Expensive system
Fragmentation data complex and
requires computational software
to extract structural information
Requires maintenance and highly
trained personnel to execute
experiments
CE–MS Capillary electrophoresis coupled
mass spectrometry where
charged metabolites are
separated by charge-to-mass
ratio, in a conductive liquid
medium, under the inﬂuence of
an electric ﬁeld.
Mass spectrometry operates by
ionization of metabolites,
separation of ionic fragments
according to their
mass-to-charge ratio, and then
detection of these separated ions
Large proteins
Ionic metabolites (organic and
inorganic)
Can resolve polar and ionic
samples that may be more
difﬁcult with GC–MS or LC–
MS
Limited sample preparation
required
Small sample requirement (few
mL)
Low reproducibility
Requires conductive liquid
medium that may not be
compatible with MS
Requires maintenance and highly
trained personnel to execute
experiments
FT-IR Based on the asymmetrical
vibrational modes of chemical
bonds in a molecule.
Electromagnetic radiation
absorption causes an increase in
characteristic vibrational energy
states depending on their
chemical structure.
Spectra reﬂect fundamental
vibrational transitions
Most metabolites
Examples:
Carbohydrates (sugars—
polysaccharides)
Fatty acids
Amino acids
Organic compounds
Lipids
Proteins
Unknown identiﬁcation using
peak pattern matching against a
database
Quantitative capabilities
Simultaneous analysis of
multiple analytes
High-throughput method
Resolved spectral features (in
comparison to NIR)
Higher signal intensity (in
comparison to NIR)
Minimal user training required
Relatively insensitive and
unselective in comparison to MS
Challenging aqueous sample
analysis. Requires short path
length transmission cells and
attenuated total reﬂectance
sampling accessories
Interferometer systems comprise
of moving parts (moving mirror).
Requires maintenance
Continued
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Table A2. Continued
Analytical
technology
Description Chemical range Advantages Limitations
NIR Based on the asymmetrical
vibrational modes of chemical
bonds in a molecule.
Electromagnetic radiation
absorption causes an increase in
characteristic vibrational energy
states depending on their
chemical structure.
Spectra reﬂect overtone and
combination vibrational bands
Most metabolites
Metabolites with asymmetrical
vibrational modes
Examples:
Carbohydrates (sugars—
polysaccharides)
Fatty acids
Amino acids
Organic compounds
Lipids
Proteins
Can analyze many types of
materials (solids, aqueous
samples, tissues etc.) without
sample preparation
Reduced instrumental
complexity and cost
NIR data more accurate and
quantitative as a result of
multivariate algorithm analysis
Minimal user training required
Absorptions are at weaker in
magnitude compared with FT-IR
Broad, overlapping spectral
features that require multivariate
algorithm analysis
Requires thorough chemical
knowledge to interpret spectral
results
Raman Analysis of scattered light from
laser-illuminated sample,
promoting vibrational excitation
(Stokes) or relaxation
(anti-Stokes) along a
symmetrical vibrational mode.
Spectra reﬂect fundamental
vibrational transitions (similar to
FT-IR)
Most metabolites
Symmetrical molecules (that are
IR inactive)
Examples:
Carbohydrates (sugars—
polysaccharides)
Fatty acids
Amino acids
Organic compounds
Lipids
Proteins
Complementary to IR spectral
information, representing
additional fundamental
vibrational modes
Simple analysis of aqueous
samples as a result of weak
water signal
No sample preparation required
Raman systems with no moving
parts, compact, portable, and
inexpensive systems
Minimal user training required
Useful for symmetric molecule
analysis (not IR active)
Insensitive technique as a result
of rare Raman scattering
Weak signals require advanced
detector ampliﬁcation
Requires laser source, may alter
sample properties as a result of
Requires thorough chemical
knowledge to interpret spectral
results
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